Harry Glorikan, a well-known consultant and expert on the diagnostics and biopharma industries, has released a new book titled, "MONEYBALL MEDICINE: Thriving in the New Data-Driven Healthcare Market," coauthored with Malorye Alison Branca.
In 2016, Glorikian published, "Commercializing Novel IVDs: Comprehensive Manual for Success," here. See also his December 2017 article on risk based regulation of diagnostics, here.
The book already sold out its first printing on Amazon; but ebooks currently are available. See the Amazon website here.
From the Amazon summary:
MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market, which includes interviews with dozens of healthcare leaders, describes the business challenges and opportunities arising for those working in one of the most vibrant sectors of the world’s economy. Doctors, hospital administrators, health information technology directors, and entrepreneurs need to adapt to the changes effecting healthcare today in order to succeed in the new, cost-conscious and value-based environment of the future. The authors map out many of the changes taking place, describe how they are impacting everyone from patients to researchers to insurers, and outline some predictions for the healthcare industry in the years to come.
Two other books on related topics in the recent weeks include FOURTH WAVE: DIGITAL HEALTH by Paul Sonnier (here), and REALIZING THE PROMISE OF PRECISION MEDICINE: Patient Data, Mobile Technology, Consumer Engagement, by Paul Cerrato and John Halamka (here).